Charles River Laboratories CRL Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's total equity?
- Charles River Laboratories (CRL) reported total equity of $2.94B in Q1 2026.
- How has Charles River Laboratories's total equity changed year-over-year?
- Charles River Laboratories's total equity decreased by 7.9% year-over-year, from $3.19B to $2.94B.
- What is the long-term trend for Charles River Laboratories's total equity?
- Over 5 years (2020 to 2025), Charles River Laboratories's total equity has grown at a 8.4% compound annual growth rate (CAGR), from $2.11B to $3.16B.
- What does total equity mean?
- The total value of the company that belongs to the shareholders.
- How do you interpret total equity?
- A consistent increase indicates growth in the company's net worth through earnings or capital contributions.
- How does total equity compare across companies?
- Used to calculate Return on Equity (ROE), a standard benchmark for performance across the industry.